Cargando…
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
Adoptive cell therapy has emerged as a powerful treatment for advanced cancers resistant to conventional agents. Most notable are the remarkable responses seen in patients receiving autologous CD19-redirected chimeric antigen receptor (CAR) T cells for the treatment of B lymphoid malignancies; howev...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818392/ https://www.ncbi.nlm.nih.gov/pubmed/29497427 http://dx.doi.org/10.3389/fimmu.2018.00283 |